Earnings Feed
Start Free
Jounce Therapeutics, Inc.·4

Feb 3, 5:48 PM ET

MURRAY RICHARD /CA/ 4

4 · Jounce Therapeutics, Inc. · Filed Feb 3, 2021

Insider Transaction Report

Form 4
Period: 2021-02-01
Jounce Therapeutics, Inc.JNCE
MURRAY RICHARD /CA/
DirectorCEO and President
Transactions
  • Award

    Common Stock

    2021-02-01+75,000→ 215,371 total
  • Award

    Common Stock

    2021-02-03+7,500→ 222,871 total
  • Award

    Stock Option (Right to Buy)

    2021-02-01+150,000→ 150,000 total
    Exercise: $11.89Exp: 2031-02-01→ Common Stock (150,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-02-01+15,000→ 15,000 total
    Exercise: $12.67Exp: 2031-02-03→ Common Stock (15,000 underlying)
Footnotes (1)
  • [F1]The option will vest quarterly in 16 equal installments following January 1, 2021.

Documents

1 file
  • 4
    wf-form4_161239250703335.xmlPrimary

    FORM 4